CMO I deficiency caused by a point mutation in exon 8 of the human CYP11B2 gene encoding steroid 18-hydroxylase (P450(C18))

Satoshi Nomoto, Guy Massa, Fumiko Mitani, Yuzuru Ishimura, Kaoru Miyahara, Katsumi Toda, Isao Nagano, Toshiyuki Yamashiro, Shohei Ogoshi, Jun Ichi Fukata, Saburo Onishi, Kozo Hashimoto, Yoshinori Doi, Hiroo Imura, Yutaka Shizuta

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Corticosterone methyloxidase I (CMO I) deficiency is an autosomal recessive disorder of aldosterone biosynthesis. To determine further the molecular genetic basis of CMO I deficiency, a patient of Turkish origin that suffered from CMO I deficiency was studied. Nucleotide sequencing of the PCR-amplified exons from the genomic DNA of this patient revealed a single point mutation CTG (leucine) → CCG (proline) at codon 461 in exon 8 of CYP11B2, which is involved in the putative heme binding site of steroid 18-hydroxylase (P450(C18)). The expression study using a cDNA introducing the point mutation revealed that the amino acid substitution totally abolishes the P450(C18) enzyme activities required for conversion of 11-deoxycorticosterone to aldosterone, even though the mutant product was detected in the mitochondrial fraction of the transfected cells. These results suggest that this point mutation causes CMO I deficiency.

Original languageEnglish
Pages (from-to)382-385
Number of pages4
JournalBiochemical and Biophysical Research Communications
Volume234
Issue number2
DOIs
Publication statusPublished - May 19 1997

Fingerprint

Cytochrome P-450 CYP11B2
Gene encoding
Corticosterone
Point Mutation
Exons
Aldosterone
Genes
Desoxycorticosterone
Biosynthesis
Enzyme activity
Amino Acid Substitution
Heme
Proline
Codon
Leucine
Cytochrome P-450 Enzyme System
Molecular Biology
Substitution reactions
Nucleotides
Complementary DNA

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

CMO I deficiency caused by a point mutation in exon 8 of the human CYP11B2 gene encoding steroid 18-hydroxylase (P450(C18)). / Nomoto, Satoshi; Massa, Guy; Mitani, Fumiko; Ishimura, Yuzuru; Miyahara, Kaoru; Toda, Katsumi; Nagano, Isao; Yamashiro, Toshiyuki; Ogoshi, Shohei; Fukata, Jun Ichi; Onishi, Saburo; Hashimoto, Kozo; Doi, Yoshinori; Imura, Hiroo; Shizuta, Yutaka.

In: Biochemical and Biophysical Research Communications, Vol. 234, No. 2, 19.05.1997, p. 382-385.

Research output: Contribution to journalArticle

Nomoto, S, Massa, G, Mitani, F, Ishimura, Y, Miyahara, K, Toda, K, Nagano, I, Yamashiro, T, Ogoshi, S, Fukata, JI, Onishi, S, Hashimoto, K, Doi, Y, Imura, H & Shizuta, Y 1997, 'CMO I deficiency caused by a point mutation in exon 8 of the human CYP11B2 gene encoding steroid 18-hydroxylase (P450(C18))', Biochemical and Biophysical Research Communications, vol. 234, no. 2, pp. 382-385. https://doi.org/10.1006/bbrc.1997.6651
Nomoto, Satoshi ; Massa, Guy ; Mitani, Fumiko ; Ishimura, Yuzuru ; Miyahara, Kaoru ; Toda, Katsumi ; Nagano, Isao ; Yamashiro, Toshiyuki ; Ogoshi, Shohei ; Fukata, Jun Ichi ; Onishi, Saburo ; Hashimoto, Kozo ; Doi, Yoshinori ; Imura, Hiroo ; Shizuta, Yutaka. / CMO I deficiency caused by a point mutation in exon 8 of the human CYP11B2 gene encoding steroid 18-hydroxylase (P450(C18)). In: Biochemical and Biophysical Research Communications. 1997 ; Vol. 234, No. 2. pp. 382-385.
@article{daa9ba95be444095a9aa033bad65fc5c,
title = "CMO I deficiency caused by a point mutation in exon 8 of the human CYP11B2 gene encoding steroid 18-hydroxylase (P450(C18))",
abstract = "Corticosterone methyloxidase I (CMO I) deficiency is an autosomal recessive disorder of aldosterone biosynthesis. To determine further the molecular genetic basis of CMO I deficiency, a patient of Turkish origin that suffered from CMO I deficiency was studied. Nucleotide sequencing of the PCR-amplified exons from the genomic DNA of this patient revealed a single point mutation CTG (leucine) → CCG (proline) at codon 461 in exon 8 of CYP11B2, which is involved in the putative heme binding site of steroid 18-hydroxylase (P450(C18)). The expression study using a cDNA introducing the point mutation revealed that the amino acid substitution totally abolishes the P450(C18) enzyme activities required for conversion of 11-deoxycorticosterone to aldosterone, even though the mutant product was detected in the mitochondrial fraction of the transfected cells. These results suggest that this point mutation causes CMO I deficiency.",
author = "Satoshi Nomoto and Guy Massa and Fumiko Mitani and Yuzuru Ishimura and Kaoru Miyahara and Katsumi Toda and Isao Nagano and Toshiyuki Yamashiro and Shohei Ogoshi and Fukata, {Jun Ichi} and Saburo Onishi and Kozo Hashimoto and Yoshinori Doi and Hiroo Imura and Yutaka Shizuta",
year = "1997",
month = "5",
day = "19",
doi = "10.1006/bbrc.1997.6651",
language = "English",
volume = "234",
pages = "382--385",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - CMO I deficiency caused by a point mutation in exon 8 of the human CYP11B2 gene encoding steroid 18-hydroxylase (P450(C18))

AU - Nomoto, Satoshi

AU - Massa, Guy

AU - Mitani, Fumiko

AU - Ishimura, Yuzuru

AU - Miyahara, Kaoru

AU - Toda, Katsumi

AU - Nagano, Isao

AU - Yamashiro, Toshiyuki

AU - Ogoshi, Shohei

AU - Fukata, Jun Ichi

AU - Onishi, Saburo

AU - Hashimoto, Kozo

AU - Doi, Yoshinori

AU - Imura, Hiroo

AU - Shizuta, Yutaka

PY - 1997/5/19

Y1 - 1997/5/19

N2 - Corticosterone methyloxidase I (CMO I) deficiency is an autosomal recessive disorder of aldosterone biosynthesis. To determine further the molecular genetic basis of CMO I deficiency, a patient of Turkish origin that suffered from CMO I deficiency was studied. Nucleotide sequencing of the PCR-amplified exons from the genomic DNA of this patient revealed a single point mutation CTG (leucine) → CCG (proline) at codon 461 in exon 8 of CYP11B2, which is involved in the putative heme binding site of steroid 18-hydroxylase (P450(C18)). The expression study using a cDNA introducing the point mutation revealed that the amino acid substitution totally abolishes the P450(C18) enzyme activities required for conversion of 11-deoxycorticosterone to aldosterone, even though the mutant product was detected in the mitochondrial fraction of the transfected cells. These results suggest that this point mutation causes CMO I deficiency.

AB - Corticosterone methyloxidase I (CMO I) deficiency is an autosomal recessive disorder of aldosterone biosynthesis. To determine further the molecular genetic basis of CMO I deficiency, a patient of Turkish origin that suffered from CMO I deficiency was studied. Nucleotide sequencing of the PCR-amplified exons from the genomic DNA of this patient revealed a single point mutation CTG (leucine) → CCG (proline) at codon 461 in exon 8 of CYP11B2, which is involved in the putative heme binding site of steroid 18-hydroxylase (P450(C18)). The expression study using a cDNA introducing the point mutation revealed that the amino acid substitution totally abolishes the P450(C18) enzyme activities required for conversion of 11-deoxycorticosterone to aldosterone, even though the mutant product was detected in the mitochondrial fraction of the transfected cells. These results suggest that this point mutation causes CMO I deficiency.

UR - http://www.scopus.com/inward/record.url?scp=0031578241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031578241&partnerID=8YFLogxK

U2 - 10.1006/bbrc.1997.6651

DO - 10.1006/bbrc.1997.6651

M3 - Article

C2 - 9177280

AN - SCOPUS:0031578241

VL - 234

SP - 382

EP - 385

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -